Skip to main content

Table 2 Main results in the total and subgroup analysis

From: Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population

Analysis model

Study groups

n

Random-effect model

Fixed-effect model

Heterogeneity

OR (95% CI)

OR (95% CI)

χ 2

P

C vs. T

Total analysis

12

1.25 (1.04 to 1.51)

1.23 (1.11 to 1.37)

33.46

0.000

 

PB

6

1.22 (1.05 to 1.42)

1.22 (1.05 to 1.42)

1.49

0.914

 

HB

6

1.30 (0.90 to 1.90)

1.25 (1.08 to 1.44)

31.93

0.000

 

ESCC

9

1.18 (1.00 to 1.39)

1.17 (1.04 to 1.32)

14.48

0.070

 

South China

3

0.93 (0.76 to 1.14)

0.93 (0.76 to 1.14)

0.71

0.702

 

North China

9

1.38 (1.12 to 1.70)

1.37 (1.21 to 1.55)

22.21

0.005

CC vs. TT

Total analysis

12

1.42 (0.99 to 2.04)

1.42 (1.15 to 1.75)

29.24

0.002

 

PB

6

1.38 (1.02 to 1.88)

1.38 (1.02 to 1.88)

0.45

0.994

 

HB

6

1.46 (0.70 to 3.04)

1.45 (1.09 to 1.93)

28.75

0.000

 

ESCC

9

1.29 (0.94 to 1.77)

1.27 (1.00 to 1.62)

12.34

0.137

 

South China

3

0.82 (0.54 to 1.25)

0.82 (0.54 to 1.24)

1.26

0.531

 

North China

9

1.72 (1.16 to 2.56)

1.73 (1.35 to 2.22)

18.97

0.015

CC vs. CT

Total analysis

12

1.09 (0.89 to 1.33)

1.09 (0.89 to 1.32)

10.90

0.452

 

PB

6

1.07 (0.80 to 1.43)

1.06 (0.80 to 1.42)

2.93

0.711

 

HB

6

1.12 (0.78 to 1.59)

1.11 (0.85 to 1.45)

7.94

0.160

 

ESCC

9

1.01 (0.80 to 1.28)

1.01 (0.80 to 1.28)

7.91

0.442

 

South China

3

0.80 (0.53 to 1.21)

0.80 (0.53 to 1.21)

1.53

0.464

 

North China

9

1.19 (0.95 to 1.50)

1.19 (0.95 to 1.50)

6.63

0.577

CC + CT vs. TT

Total analysis

12

1.35 (1.06 to 1.72)

1.37 (1.17 to 1.59)

26.54

0.005

 

PB

6

1.36 (1.10 to 1.69)

1.36 (1.10 to 1.69)

4.10

0.536

 

HB

6

1.39 (0.86 to 2.23)

1.37 (1.11 to 1.70)

22.44

0.000

 

ESCC

9

1.28 (1.04 to 1.59)

1.28 (1.08 to 1.52)

11.73

0.164

 

South China

3

0.97 (0.73 to 1.28)

0.97 (0.73 to 1.28)

0.11

0.947

 

North China

9

1.52 (1.14 to 2.02)

1.58 (1.32 to 1.89)

18.30

0.019

CC vs. TT + CT

Total analysis

13

1.35 (1.03 to 1.76)

1.34 (1.13 to 1.59)

26.94

0.008

 

PB

7

1.41 (1.06 to 1.89)

1.43 (1.13 to 1.81)

8.26

0.219

 

HB

6

1.30 (0.79 to 2.14)

1.25 (0.98 to 1.60)

18.16

0.003

 

ESCC

9

1.14 (0.88 to 1.47)

1.12 (0.90 to 1.40)

10.22

0.250

 

South China

3

0.82 (0.56 to 1.20)

0.81 (0.56 to 1.19)

1.63

0.443

 

North China

10

1.55 (1.17 to 2.06)

1.53 (1.26 to 1.86)

17.20

0.046

  1. PB population-based, HB hospital-based, ESCC esophageal squamous cell carcinoma, South China including Taiwan, Jiangsu, and Guangxi; North China including Shaxi, Xinjiang, Gansu, Ningxia, Shandong, and Henan.